- Veteran Plant Executive to Direct Further Enhancements to Manufacturing, Packaging, Distribution Operations
- 17 Years Experience Includes Senior Manufacturing, Engineering Positions With Major Pharmaceutical, Consumer Products Companies
IRVING, Texas, Oct. 16 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (Nasdaq: CARN) today announced that William Carrion, whose 17 years of experience includes key manufacturing positions with major pharmaceutical and consumer products corporations, has been appointed vice president, operations. Carrion, 41, will be in charge of manufacturing, contract manufacturing, packaging, distribution and maintenance at Carrington's Irving, Texas, facility.
"We expect William to continue enhancing the effectiveness, throughput and cost efficiency of our operations in Texas," said Carlton E. Turner, president and chief executive officer. "He has a long history of demonstrated success in cost and efficiency improvements, inventory control, project management, team building, new product introductions and meeting deadlines."
Carrion added, "I look forward to making an immediate contribution to Carrington operations. This is an exceptional opportunity to work with a first-rate team operating an ISO-certified facility."
Carrion has held plant management or engineering positions with Colgate-Palmolive, Procter and Gamble, Bristol-Meyers Squibb and Eli Lilly. Most recently, Carrion was director of manufacturing for Cytosol Laboratories Inc.of Braintree, Massachusetts, a developer and manufacturer of products used in blood preservation and rejuvenation of blood. Prior to that he was plant manager for Millipore Corporation of Bedford, Massachusetts, which develops and manufactures membrane products used in medical devices, bioprocess purification and microelectronics gases purification.
He has a master of business administration degree in management, cumlaude, from Universidad del Turabo in Caguas, Puerto Rico, and a bachelor of science degree in chemical engineering from the University of Puerto Rico inMayguez.
Carrington Laboratories, Inc., is an ISO 9001-certified, research-based biopharmaceutical company currently utilizing naturally occurring complex carbohydrates to manufacture and market products for mucositis, radiation dermatitis, wound and oral care; manufacture and market the nutraceutical raw materials Manapol(R) and Hydrapol(TM); and market consumer products under the AloeCeuticals(R) brand. Carrington's technology is protected by more than 120 patents in 26 countries. Select products are honored with the internationally coveted CE mark, recognized by more than 20 countries around the world.
Certain statements in this release concerning Carrington may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to: subsequent changes in plans by the company's management; delays or problems in production; changes in the regulatory process; changes in market trends; and a number of other factors and risks described from time to time in the Company's filings with the Securities & Exchange Commission, including the Form 10Q filed August 14, 2002.